PFRMAT FN
TARGET T0573
MODEL 1
Binding site: 72, 80, 84, 94, 95, 96, 98, 169, 171, 173, 175, 187, 190, 192, 193, 194, 197, 199, 207, 239, 240, 247, 249, 261, 263, 265, 267, 269, 280, 301, 305, 308, 309,
Comment: Model based on 1ODM - Ligand:AKG_A_3(1GP5)[Kd=-0.74]; DQH_A_6(1GP5)[Kd=-3.08]; FE_A_2(1GP5)[Kd=-1.12]; FE2_A_2(1GP6)[Kd=-1.12]; QUE_A_6(1GP6)[Kd=-3.30]; SIN_A_3(1GP6)[Kd=-0.75]; AKG_A_2(1GP4)[Kd=-0.18]; ACV_A_4(2BJS)[Kd=-1.86]; ACV_A_5(2BJS)[Kd=-0.33]; IP1_D_4(1QJE)[Kd=-9.20]; ACS_D_4(1QJF)[Kd=-2.05]; ACC_A_4(1QIQ)[Kd=-3.52]; SCV_A_4(1HB4)[Kd=-1.07]; SCV_A_4(1HB3)[Kd=-1.22]; SCV_A_4(1HB2)[Kd=-1.23]; OCV_A_4(1HB1)[Kd=-3.31]; ASV_A_6(1ODM)[Kd=-3.36]; SO4_A_3(1ODM)[Kd=-0.49]; APV_A_4(1ODN)[Kd=-1.95]; ASV_A_4(1OBN)[Kd=-3.20]; NO_A_5(1OBN)[Kd=-1.28]; ASV_A_6(1OC1)[Kd=-3.94]; CDH_A_4(1UZW)[Kd=-2.71]; HCG_A_4(1W03)[Kd=-0.58]; HCG_A_5(1W04)[Kd=-2.54]; NO_A_6(1W04)[Kd=-1.39]; 
END
